Crosstalk between gut microbiota and antidiabetic drug action

doi:10.4239/wjd.v10.i3.154

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11718)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

912

WORD

177

HTML

6929

Figures (1-1)

194

Sum=8212

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

803

Download

583

Sum=1386

Publishing Process of This Article

Item

Count

Browse

863

Download

1257

Sum=2120

Mar 15, 2019 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Mar 15, 2019; 10(3): 154-168
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.154

Open in New Tab Full Size Figure Download Figure

Figure 1 Crosstalk between metformin action and gut microbiota. GLP1: Glucagon-like peptide-1; GLP2: Glucagon-like peptide-2; LPS: Lipopolysaccharide; SCFA: Short-chain fatty acid.

Citation: Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes 2019; 10(3): 154-168
URL: https://www.wjgnet.com/1948-9358/full/v10/i3/154.htm
DOI: https://dx.doi.org/10.4239/wjd.v10.i3.154